Christina Yip

Christina Yip appears in our data through filings on Pacgen Life Science Corporation shares, published by SEDI. The record holds 35 filings, for trades running from 25 January 2016 to 22 February 2018.

The open-market side counts 32 purchases for €6,496 alongside 1 sale for €584. The net balance comes to €5,913 on the buying side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2018, the count stands at 1 purchase and no sales.

Half of the purchases are above €178 and half below. Across 30 purchases, this insider has always bought alone, with no colleague buying within 30 days.

The newest entry dates from 27 February 2018: an open-market purchase of €692, in Pacgen Life Science Corporation. Filings reach the SEDI feed a median of 4 days after the trade. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.